Atai Life Sciences N.V.
(NQ:
ATAI
)
1.190
-0.030 (-2.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atai Life Sciences N.V.
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Psychedelic Stock Gainers And Losers From March 6, 2023
March 06, 2023
Via
Benzinga
Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce
March 06, 2023
The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as its plan to streamline its workforce with significant...
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
March 06, 2023
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Via
Benzinga
Atai Layoffs 2023: What to Know About the Latest ATAI Job Cuts
March 06, 2023
Atai Life Sciences has just announced 30% job cuts. Here's how investors should be interpreting the Atai layoffs as ATAI stock rises.
Via
InvestorPlace
Atai Life Sciences: Long On Money; Short On Success
March 06, 2023
A review of Atai Life Sciences' latest quarterly financials, the history of its stock price performance, and the price forecasts for the stock over the next 12 months.
Via
Talk Markets
Wall Street Thinks These 2 Penny Stocks Could Go Parabolic
February 09, 2023
Wall Street is bullish on these two beaten-down healthcare stocks.
Via
The Motley Fool
atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates
March 06, 2023
From
atai Life Sciences
Via
GlobeNewswire
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 03, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
March 02, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 01, 2023
Via
Benzinga
atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
atai Life Sciences
Via
GlobeNewswire
Psychedelic Stock Gainers And Losers From February 28, 2023
February 28, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 27, 2023
February 27, 2023
Via
Benzinga
"Rags-To-Riches" Portfolio Outpacing S&P 500 By 2-To-1 Margin
February 27, 2023
The
Via
Talk Markets
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
February 26, 2023
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
February 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
February 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
February 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
February 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
February 20, 2023
Via
Benzinga
"Rags-To-Riches" Portfolio Underperforming YTD
February 19, 2023
The munKNEE
Via
Talk Markets
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
February 17, 2023
A look at the performance of the six largest psychedelic stocks by market capitalization.
Via
Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
February 17, 2023
Via
Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
February 16, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
February 15, 2023
Via
Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
February 14, 2023
Via
Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
February 13, 2023
Via
Benzinga
Major Psychedelic Compound-Based Stocks UP 13% YTD
February 11, 2023
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances.
Via
Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
February 10, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
February 09, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.